Literature DB >> 12522522

Torsade de pointes associated with the administration of intravenous haloperidol.

Hesham A Hassaballa1, Robert A Balk.   

Abstract

Torsade de pointes is a malignant dysrhythmia that has been reported in a variety of clinical settings and associated with several pharmacologic agents. Patients with a prolonged QTc for heart rate are at higher risk for the development of this arrhythmia. We review the literature supporting the relationship of haloperidol to the development of this malignant dysrhythmia. Clinicians in the critical care setting should be aware of potentially lethal drug-induced ventricular tachydysrhythmias such as torsade de pointes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522522     DOI: 10.1097/00045391-200301000-00013

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  9 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

Review 2.  Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Authors:  Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; Mathieu Molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; Nicholas Moore
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  In-Hospital Haloperidol Use and Perioperative Changes in QTc-Duration.

Authors:  M T Blom; S Jansen; A de Jonghe; B C van Munster; A de Boer; S E de Rooij; H L Tan; N van der Velde
Journal:  J Nutr Health Aging       Date:  2015-05       Impact factor: 4.075

Review 4.  Intramuscular olanzapine: a review of its use in the management of acute agitation.

Authors:  Antona J Wagstaff; Jane Easton; Lesley J Scott
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Does haloperidol prophylaxis reduce ketamine-induced emergence delirium in children?

Authors:  Mostafa A M Amr; Tarek Shams; Hamid Al-Wadani
Journal:  Sultan Qaboos Univ Med J       Date:  2013-05-09

6.  Differential changes in QTc duration during in-hospital haloperidol use.

Authors:  Marieke T Blom; Abdennasser Bardai; Barbara C van Munster; Mei-Ing Nieuwland; Hendrik de Jong; Daniel A van Hoeijen; Anne M Spanjaart; Anthonius de Boer; Sophia E de Rooij; Hanno L Tan
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

7.  The injection rate of intravenous midazolam significantly influences the occurrence of paradoxical reaction in pediatric patients.

Authors:  Abbas Moallemy; Saeed Hoseini Teshnizi; Masood Mohseni
Journal:  J Res Med Sci       Date:  2014-10       Impact factor: 1.852

8.  Two Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of Intramuscular Antipsychotics.

Authors:  Nasratullah Wahidi; Katie M Johnson; Allen Brenzel; Jose de Leon
Journal:  Case Rep Psychiatry       Date:  2016-08-15

9.  Sodium Valproate versus Continuous Infusion of Haloperidol in Management of Agitated Critically Ill Patients.

Authors:  Ramadan Khalil; Mohamed Soliman; Mohamed Omer; Kamel Abdel Aziz; Khaled Hussein
Journal:  Open Access Maced J Med Sci       Date:  2019-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.